Summary:
The main goal of Part A of this study is to assess the safety, reactogenicity, and immunogenicity of the study vaccine candidates. The main goal of Part B of this study is to assess the safety, reactogenicity, and immunogenicity of the mRNA-1283.529 booster vaccine candidate.
Criteria:· 12+ YEARS OF AGE
· IN GOOD HEALTH
· 12-18 REQUIRES A COVID-19 VACCINE
· 19+ REQUIRES 1 BOOSTER VACCINE
· NO PLACEBO
Qualified Participants May Receive:
TOTAL COMPENSATION FOR PARTICIPANT: $880